丹诺医药(苏州)股份有限公司（以下称“公司”，股票代码：06872）于2026年7月3日发布2026年6月股份变动月报表。公告显示，截至2026年6月30日，公司已发行普通股（H股）数量为52,328,926股，与5月底数量一致，报告期内无新增发行、购回、注销或股份回购后持作库藏的情况。
根据公告，本月底公司已发行股本（不含库存股）与上月底相同，均为52,328,926股，登记的注册股本为人民币52,328,926元。公司确认，截至本月末，已满足香港联合交易所有限公司的公众持股量要求。报告期内，公司无可换股债券、股权激励及其他权益工具的变动事宜。
截至6月底，公司股本结构整体保持稳定。本次月报表由董事会主席、执行董事、首席执行官兼总经理马振坤签署。公司重申将持续依照香港联交所《上市规则》及相关法律法规的要求合规运作。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.